نتایج جستجو برای: seroprotection

تعداد نتایج: 374  

2014
Paul Gillard Didier Giet Stéphane Heijmans Mamadou Dramé Karl Walravens François Roman

BACKGROUND Older individuals often have a reduced immune response to influenza vaccination, which might be improved by administering a higher vaccine dose. We compared the immune response to two single doses of the AS03A-adjuvanted H5N1 pandemic vaccine (3.75 μg hemagglutinin of A/Vietnam/1194/2004) with that of two double vaccine doses (7.5 μg hemagglutinin) in adults aged ≥61 years. Here we r...

Journal: :Japanese Journal of Infectious Diseases 2021

The quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Men-ACWY-D) has been licensed for use in Japan since 2014. An earlier registration study demonstrated the immunogenicity of a single dose Japanese adults, wherein against serogroup C was lowest. determination potential to increase response with second was, therefore, interest. This (NCT02591290) evaluated safety ...

Journal: :Health technology assessment 2010
K G Nicholson K R Abrams S Batham T W Clark K Hoschler W S Lim M Medina J S Nguyen-Van-Tam R C Read F C Warren M Zambon

OBJECTIVES To evaluate the immunogenicity of a two-dose schedule of Baxter cell-cultured, non-adjuvanted, whole-virion H1N1 vaccine, and GlaxoSmithKline AS03(A)-adjuvanted split-virion H1N1 vaccine with respect to the EU Committee for Medicinal Products for Human Use (CHMP) and the US Food and Drug Administration (FDA) licensing criteria. DESIGN An age-stratified, randomised, observer-blind, ...

Journal: :Open Forum Infectious Diseases 2022

Abstract Background Three-dose series of conventional alum-adjuvanted Hepatitis B surface antigen (HBsAg)-based vaccines achieve seroprotection rates (SPRs) 35-70% in PLWH. HepB-CpG, a HBsAg vaccine adjuvanted with TLR-9 agonist, achieves high SPR immunocompetent adults 2-dose regimen, but limited data exist Methods A5379 is an ongoing prospective, open-label study to evaluate immunogenicity th...

Journal: :The Indian journal of medical research 2004
K Krishnamurthy George T John Priya Abraham Chakko K Jacob

BACKGROUND & OBJECTIVES Conventional hepatitis B vaccine protocols do not provide rapid seroprotection against hepatitis B. This randomized controlled trial was carried out to investigate the efficacy of granulocyte macrophage-colony stimulating factor (GM-CSF) augmented double-dose vaccine protocol in voluntary kidney donors prior to donor nephrectomy. METHODS A total of 54 kidney donors, wh...

2014
M. REZAEI S. NOORIPOOR R. GHORBANI F. RAMEZANSHAMS S. MAMISHI S. MAHMOUDI

INTRODUCTION There are controversies over the long-term persistence of post vaccination immunity to hepatitis B and the need for booster doses of the vaccine. The aim of this study was to verify antibody levels of antibody against hepatitis B virus surface antigen (anti-HBs) in children aged 1 to 15 years who received vaccination against hepatitis B in the central province of Iran, Semnan. MA...

Background: Hemodialysis (HD) patients are at an increased risk of acquiring the hepatitis B (HB) virus and having lower protective antibody levels as well as shorter durations of seroprotection. This study aims to determine the immune response of HB vaccination in HD patients referring to dialysis centers of the Tehran North Health Network. Materials and Methods: This descriptive study was co...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید